Cutting Edge: Ubiquitin-Specific Protease 4 Promotes Th17 Cell Function under Inflammation by Deubiquitinating and Stabilizing RORγt

被引:65
|
作者
Yang, Jing [1 ]
Xu, Peng [2 ]
Han, Lei [3 ]
Guo, Zhixiang [2 ]
Wang, Xiuwen [3 ]
Chen, Zuojia [1 ]
Nie, Jia [1 ]
Yin, Shuying [1 ]
Piccioni, Miranda [1 ]
Tsun, Andy [1 ]
Lv, Ling [3 ]
Ge, Shenglin [2 ]
Li, Bin [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, Shanghai 200025, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Hefei 230032, Peoples R China
[3] Fudan Univ, Div Rheumatol, Huashan Hosp, Shanghai 200040, Peoples R China
来源
JOURNAL OF IMMUNOLOGY | 2015年 / 194卷 / 09期
关键词
TRANSCRIPTION FACTOR FOXP3; REGULATORY T; TGF-BETA; DIFFERENTIATION; RECEPTOR; T(H)17; BALANCE; IL-6;
D O I
10.4049/jimmunol.1401451
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ROR gamma t is a key transcription factor that controls the development and function of inflammatory Th17. The mechanisms that regulate RORgt stability remain unclear. We report that Th17 cells highly express the deubiquitinase ubiquitin-specific protease (USP) 4, which is essential for maintaining RORgt and Th17 cell function. Inhibition of the catalytic activity of USP4 with vialinin A, a compound derived from Chinese traditional medicine, dampened Th17 differentiation. USP4 interacted and deubiquitinated K48-linked polyubiquitination of RORgt, thereby promoting ROR gamma t function and IL-17A transcription. Interestingly, TGF-beta plus IL-6 enhanced USP4-mediated deubiquitination of ROR gamma t. Moreover, USP4 and IL-17 mRNA, but not RORgt mRNA, were significantly elevated in CD4(+) T cells from patients with rheumatic heart disease. Thus, USP4 could be a novel therapeutic target for the treatment of Th17-modulated autoimmune diseases.
引用
收藏
页码:4094 / 4097
页数:4
相关论文
empty
未找到相关数据